The Estee Lauder Companies (EL)
(Delayed Data from NYSE)
$63.28 USD
-2.58 (-3.92%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $63.50 +0.22 (0.35%) 7:58 PM ET
5-Strong Sell of 5 5
F Value D Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$63.28 USD
-2.58 (-3.92%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $63.50 +0.22 (0.35%) 7:58 PM ET
5-Strong Sell of 5 5
F Value D Growth B Momentum F VGM
Zacks News
Estee Lauder (EL) Beats on Q4 Earnings and Revenues
by Zacks Equity Research
Estee Lauder (EL) delivered better-than-expected earnings and revenues in the fourth quarter fiscal 2017 results.
What's in the Offing for Estee Lauder (EL) in Q4 Earnings?
by Zacks Equity Research
Estee Lauder (EL) has been benefiting from its strategic acquisitions, cost saving initiatives and e-Commerce growth. However, changing consumer preferences have been posing concerns.
Ulta Beauty's Growth Efforts Look Promising: Time to Buy?
by Zacks Equity Research
Ulta Beauty (ULTA) looks promising on the back of its splendid surprise history, robust marketing initiatives and solid e-Commerce as well as omni-channel growth.
Estee Lauder Ahead of Industry: What's Behind the Rally?
by Zacks Equity Research
Estee Lauder Companies (EL) shares have been gaining momentum driven by brand strength, rising demand for beauty products and a strong presence in emerging markets.
Ulta Beauty (ULTA) Surpasses Industry: What's Driving it?
by Zacks Equity Research
Ulta Beauty, (ULTA) has been in investor's good books for quite some time now, given its robust earnings history, solid stock momentum and sound operational strategies.
Estee Lauder (EL) Invests in DECIEM, Strengthens Portfolio
by Zacks Equity Research
In order to strengthen its beauty portfolio further, Estee Lauder Companies Inc. (EL) recently invested in DECIEM -- a fast-growing multi-brand company. However, terms of the investment were not disclosed.
Why Is Estee Lauder (EL) Up 2.9% Since the Last Earnings Report?
by Zacks Equity Research
Estee Lauder (EL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Will Estee Lauder's Strategic Efforts Help Gain Momentum?
by Zacks Equity Research
Estee Lauder Companies, Inc. (EL) has been gaining momentum of late. The company is well-positioned in the consumer product categories on the back of a strong portfolio, constant innovation and robust acquisitions.
Estee Lauder (EL) Beats on Q3 Earnings & Sales, View Intact
by Zacks Equity Research
Estee Lauder Companies, Inc. (EL) reported third-quarter fiscal 2017 results, wherein adjusted earnings of 91 cents per share were significantly ahead of both the prior-year figure and the Zacks Consensus Estimate of 73 cents.
Estee Lauder (EL) Prospects Look Bleak: Time to Sell?
by Zacks Equity Research
Cosmetics giant, Estee Lauder Companies Inc. (EL) has been in troubled waters lately.
Estee Lauder (EL) Beats Earnings, Cuts View on Currency Woes
by Zacks Equity Research
Estee Lauder Companies Inc. (EL) posted mixed second-quarter fiscal 2017 results, wherein earnings beat the Zacks Consensus Estimate, revenues missed the same.
Estee Lauder (EL) Beats on Q2 Earnings; Lags on Revenues
by Zacks Equity Research
Estee Lauder (EL) beats earnings in second quarter fiscal 2017.
The Zacks Analyst Blog Highlights: Clorox, Estee Lauder and Coty
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Clorox, Estee Lauder and Coty
3 Consumer Staple Stocks to Bet on this Earnings Season
by Zacks Equity Research
These 3 companies are taking advantage of a booming economy and rising consumer spending.
Estee Lauder (EL) to Report Q2 Earnings: A Beat in Store?
by Zacks Equity Research
We expect Estee Lauder Companies Inc. (EL) to beat estimates when it reports second-quarter fiscal 2017 results on Feb 2, 2017.
Estee Lauder (EL) Gains Despite Headwinds: Time to Hold?
by Zacks Equity Research
Cosmetics giant, Estee Lauder Companies Inc. (EL) has been in troubled waters lately. Lackluster retail growth in Hong Kong and China, lower tourist rates in New York and Florida.
Will Estee Lauder Benefit from the Too Faced Acquisition?
by Zacks Equity Research
Cosmetics giant Estee Lauder Companies Inc. (EL) has completed the acquisition of feminine cosmetics brand Too Faced.
Estee Lauder (EL) Slips to Sell: What's Wrong with the Stock?
by Zacks Equity Research
Cosmetics giant, Estee Lauder Companies Inc. (EL) has recently slipped to the red and seems to be in troubled waters at the moment.